Increasing the success of liver transplants by managing levels of anti-rejection drugs

Approximately 600 children receive liver transplants each year in the United States. The use of immunosuppressant drug therapy, namely calcineurin inhibitors (CNIs) such as cyclosporine and tacrolimus, has decreased the risk of liver rejection and increased patient survival rates. While these medications can aid positive outcomes, high levels of CNIs can cause seizures and kidney damage, and low levels increase the risk of rejection of the transplanted liver. A study in the June issue of The Journal of Pediatrics discusses an approach to managing the levels of CNIs to keep them within a safe range for each patient in order to minimize risks and maximize success.

John C. Bucuvalas, MD, and colleagues from Cincinnati Children's Hospital Medical Center and Intermountain Health Center employed a method of controlling the blood levels of CNIs to stay within target ranges for individual patients. The study involved 217 patients, aged 6 months to 21 years, who received liver transplantation at least three months before the start of the study.

In the past, doctors relied on their experience to make decisions about how and when to change CNI dosages. The method in this study used a four-step process of care that allows the dose to be changed only when the CNI blood levels fall outside certain ranges based on each patient's previous responses to dosage changes. A team of transplantation experts used a statistical process control methodology and a novel Web-based system to review each patient's CNI levels to determine potential toxicity, possible modification of the patient's target range due to post-transplant complications, excessive variation of immunosuppressant levels in the blood, and if the CNI levels were within an acceptable range for that particular patient. The team then used the data to determine if the patient's medication required adjustment to keep the levels within a safe range.

Initially, only 50% of CNI levels were within the

Contact: Monica Helton
Elsevier Health Sciences

Page: 1 2

Related medicine news :

1. Increasing radiation dose shortens treatment time for women who choose breast sparing treatment
2. Increasing survival of organ transplant patients by reducing time interval for transported organs
3. Increasing numbers of California teens abuse over-the-counter cold medicine
4. Increasing role of acetaminophen in acute liver failure in the United States
5. Increasing benefit seen in novel drug that treats Gleevec resistance
6. Controlling prescription drug expenditures: a case report of success
7. AASM to school-bound: Sleep is the right ingredient for academic success
8. Physician-researchers often less successful in obtaining NIH funding
9. Born to lose: How birth weight affects adult health and success
10. Energy Up demonstrates success as obesity intervention program for inner-city girls
11. Help for pediatricians in treating behavioral health problems only partially successful

Post Your Comments:

(Date:9/1/2020)... , ... September 01, 2020 , ... ... has completed $3 million convertible note financing, which will be used to accelerate ... the funds from this financing, the company will continue to expand its customer ...
(Date:8/31/2020)... ... , ... Cardiothoracic surgeons at Allegheny General Hospital (AGH), part ... (CMU) to develop a new heart monitoring device designed to serve as an ... AGH/CMU team was recently awarded a “Trailblazer” grant from the National Institutes of ...
(Date:8/31/2020)... NEW YORK (PRWEB) , ... August 31, 2020 , ... ... On September 1, Cerebral Palsy Alliance Research Foundation (CPARF) is thrilled to launch its ... cerebral palsy research. A fully virtual challenge, STEPtember meets everyone wherever they are at ...
(Date:8/31/2020)... ... 31, 2020 , ... The pandemic and topsy-turvy economic outlook continues to put financial strain on ... ways to trim the fat from our monthly expenses and put more into savings, if ... that you have a financial safety net in place in case something were to happen ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... intended to improve outcomes for patients with advanced heart failure, today announced that ... grant in the amount of $555,358 from the National Heart, Lung, and Blood ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... ... Lab ( https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, conducted tests on Q&J’s ... against the COVID-19 virus than many other masks. Q&J face masks have both ...
(Date:9/2/2020)... ... , ... U.S. Dermatology Partners is excited to welcome Board-Certified Dermatologist ... Bethesda Dermatopathology Lab. , Jonathan Lee, MD grew up in the California ... went on to receive his M.D. with Honors from Harvard Medical School and pre-doctoral ...
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are ... (CDC), About 3% of breast cancers (about 7,500 women per year) and 10% of ... and BRCA2 genes. Both genes are detectable in the Women’s Excellence Genetic Testing ...
Breaking Medicine Technology:
Cached News: